UCSF home page UCSF home page About UCSF UCSF Medical Center
UCSF navigation bar
photos












News & Highlights

  • Dr. Doug Bauer Appointed to FDA Advisory Committee

    Doug Bauer, MD, has been appointed to a Food and Drug Administration (FDA) review panel that will provide independent advice about drugs that have been submitted to the FDA for approval. The only general internist on a 9-member panel, he will serve on the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) for a term that runs through June 2018.

    The committee meets two to three times a year to review drugs that have been submitted to the FDA. Doug says that there is a lot of value in assessing these potential new medications from an independent standpoint. "There is a great deal of tension between making a quick decision and maintaining public safety. The pharmaceutical companies would like there to be a fast approval process but we have to determine that the drugs considered for approval are effective and safe."

    Information about the FDA BRUDAC committee, including meeting materials and the committee charter, are available at the FDA Advisory Committee website.

  • Dr. Nicole Appelle Receives 2016 Excellence in Teaching Award

    The UCSF Academy of Medical Educators has awarded Nicole Appele, MD, the 2016 Excellence in Teaching Award.

    The Excellence in Teaching Awards are peer-nominated and recognize teachers who are dedicated to education. As described on the Academy of Medical Educators website: "These teachers are 'unsung heroes' who demonstrate daily their dedication to education and teach in a manner that creates an encouraging and intellectually stimulating environment, which promotes critical thinking and learning."

    To read more about the Excellence in Teaching Awards, visit "http://meded.ucsf.edu/cfe/academy-excellence-teaching-awards

  • Dr. Tung Nguyen Selected as Member of PCORI Panel

    Tung Nguyen, MD, has been selected to the Advisory Panel on Addressing Disparities of the Patient-Centered Outcomes Research Institute (PCORI). Membership on the panel is for a term of 3 years. The priorities of the panel are to identify potential differences in prevention, diagnosis, or treatment effectiveness, or preferred clinical outcomes across patient populations and the healthcare required to achieve best outcomes in each population.

    More information about the PCORI Advisory Panel on Addressing Disparities is available on the PCORI website

Residency Spotlight

The application deadline for the 2017-18 academic year for the SFGH and UC Primary Care Internal Medicine programs is November 15, 2016.

Please refer to each program's section for details and contact information.

Calendar